332 related articles for article (PubMed ID: 3157564)
21. Inhibin suppresses luteinizing hormone (LH)-releasing hormone self-priming: direct action on follicle-stimulating hormone secretion and opposition of estradiol-enhanced LH secretion.
Culler MD
Endocrinology; 1992 Mar; 130(3):1605-14. PubMed ID: 1537310
[TBL] [Abstract][Full Text] [Related]
22. Activation of gamma-aminobutyric acid B-receptors abolishes naloxone-stimulated luteinizing hormone release.
Masotto C; Negro-Vilar A
Endocrinology; 1987 Dec; 121(6):2251-5. PubMed ID: 2824183
[TBL] [Abstract][Full Text] [Related]
23. Effects of naloxone on pulsatile luteinizing hormone in experimental hyperprolactinemia.
Lafuente A; Marco J; Moreno ML; Esquifino AI
Vet Hum Toxicol; 1994 Dec; 36(6):529-32. PubMed ID: 7900272
[TBL] [Abstract][Full Text] [Related]
24. Interaction between the posterior pituitary and LHRH in the control of LH secretion.
Froehlich JC; Neill MA; Ben-Jonathan N
Peptides; 1985; 6 Suppl 1():127-31. PubMed ID: 3931062
[TBL] [Abstract][Full Text] [Related]
25. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
Kalra PS; Fuentes M; Sahu A; Kalra SP
Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
[TBL] [Abstract][Full Text] [Related]
26. Effects of gonadotropin-releasing hormone and its agonists on prolactin secretion from normal and tumorous pituitary cells.
Lamberts SW; Uitterlinden P; Reubi JC; de Jong FH
Neuroendocrinology; 1989 Feb; 49(2):157-63. PubMed ID: 2524674
[TBL] [Abstract][Full Text] [Related]
27. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
Devorshak-Harvey E; Bona-Gallo A; Gallo RV
Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of beta-endorphin on gonadotropin-releasing hormone and thyrotropin-releasing hormone releasing activity in cultured rat anterior pituitary cells.
Sánchez-Franco F; Cacicedo L
Horm Res; 1986; 24(1):55-61. PubMed ID: 2944810
[TBL] [Abstract][Full Text] [Related]
29. Suppression of plasma luteinizing hormone by prolactin in the male rat.
Winters SJ; Loriaux DL
Endocrinology; 1978 Mar; 102(3):864-8. PubMed ID: 743999
[TBL] [Abstract][Full Text] [Related]
30. Release of dynorphin-like immunoreactivity from rat adenohypophysis in vitro during inhibition of anterior pituitary hormone secretion from individual cell types.
Schwaninger M; Knepel W; Döhler KD; Sandow J
Endocrinology; 1987 Jul; 121(1):167-74. PubMed ID: 2885174
[TBL] [Abstract][Full Text] [Related]
31. Naloxone blocks the effects of delta 9-tetrahydrocannabinol on serum luteinizing hormone and prolactin in rats.
Kumar MS; Simpkins JW
Subst Alcohol Actions Misuse; 1983; 4(5):347-53. PubMed ID: 6322367
[TBL] [Abstract][Full Text] [Related]
32. Castration induces luteinizing hormone (LH) secretion in hypophysectomized pituitary-grafted rats receiving pulsatile LH-releasing hormone infusions.
Strobl FJ; Gilmore CA; Levine JE
Endocrinology; 1989 Mar; 124(3):1140-4. PubMed ID: 2645111
[TBL] [Abstract][Full Text] [Related]
33. The actions of prostaglandin E2, naloxone and testosterone on starvation-induced suppression of luteinizing hormone-releasing hormone and luteinizing-hormone secretion. In vitro and in vivo studies.
Küderling I; Dorsch G; Warnhoff M; Pirke KM
Neuroendocrinology; 1984 Dec; 39(6):530-7. PubMed ID: 6392920
[TBL] [Abstract][Full Text] [Related]
34. Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapy.
Elkind-Hirsch KE; Platia MP; Schiff I
J Reprod Med; 1987 Jan; 32(1):5-9. PubMed ID: 3550065
[TBL] [Abstract][Full Text] [Related]
35. The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies.
Hyde JF; Ben-Jonathan N
Endocrinology; 1989 Aug; 125(2):736-41. PubMed ID: 2526728
[TBL] [Abstract][Full Text] [Related]
36. Antagonism of beta-endorphin-induced prolactin release by alpha-melanocyte-stimulating hormone and corticotropin-like intermediate lobe peptide.
Wardlaw SL; Smeal MM; Markowitz CE
Endocrinology; 1986 Jul; 119(1):112-8. PubMed ID: 3013583
[TBL] [Abstract][Full Text] [Related]
37. Further evidence that prolactin does not affect gonadotropin release at pituitary level.
Hetzel WD; Schneider PM; Pfeiffer EF
Horm Metab Res; 1987 Nov; 19(11):555-62. PubMed ID: 3323020
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y enhances the release of luteinizing hormone (LH) induced by LH-releasing hormone.
Crowley WR; Hassid A; Kalra SP
Endocrinology; 1987 Mar; 120(3):941-5. PubMed ID: 3542517
[TBL] [Abstract][Full Text] [Related]
39. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
[TBL] [Abstract][Full Text] [Related]
40. The paradoxical stimulatory effect of morphine on LH secretion is dose-dependent and naloxone-reversible.
Van Vugt DA; Baby N; Stewart M; Reid RL
Neuroendocrinology; 1989 Jul; 50(1):109-16. PubMed ID: 2755561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
